Source: Eur Respir J 2004; 24 : 890-891
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sofia M., Maniscalco M., Carratu P., Resta O.. End points for pulmonary arterial hypertension: a way backward. Eur Respir J 2004; 24 : 890-891

Member's Comments

No comment yet.

Related content which might interest you: Predicting survival in pulmonary arterial hypertension: time to move forward Source: Eur Respir J 2010; 35: 958-959 Year: 2010 End points in pulmonary arterial hypertension: the way forward Source: Eur Respir J 2004; 23: 947-953 Year: 2004 Looking backwards: is it time to assess veno-atrial interactions in pulmonary arterial hypertension? Source: Eur Respir J, 54 (4) 1901598; 10.1183/13993003.01598-2019 Year: 2019 Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm Source: Eur Respir J 2015; 46: 299-302 Year: 2015 Treatment of right heart failure on pulmonary arterial hypertension: is going left a step in the right direction? Source: Eur Respir Rev 2009; 19: 4-6 Year: 2010 Pulmonary hypertension Source: Eur Respir Rev 2013; 22: 20-25 Year: 2013 Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease Source: Eur Respir Rev 2011; 20: 236-242 Year: 2011 Inflammation in pulmonary arterial hypertension: is it time to quell the fire? Source: Eur Respir J 2014; 43: 685-688 Year: 2014 Learning to pair therapies and the expanding matrix for pulmonary arterial hypertension: is more better? Source: Eur Respir J 2006 Oct 01;28(4):683-686 Year: 2006 Is right heart catheterisation still a fundamental part of the follow-up assessment of pulmonary arterial hypertension? The argument against Source: Eur Respir J, 52 (1) 1800996; 10.1183/13993003.00996-2018 Year: 2018 Pulmonary arterial hypertension: bridging the present to the future Source: Eur Respir Rev 2012 21: 267-270 Year: 2012 COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey Source: ERJ Open Res, 6 (4) 00520-2020; 10.1183/23120541.00520-2020 Year: 2020 Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed Source: Eur Respir J 2010; 36: 986-990 Year: 2010 REVEAL: a contemporary US pulmonary arterial hypertension registry Source: Eur Respir Rev 2012; 21: 8-18 Year: 2012 Pulmonary arterial hypertension: treatment options Source: International Congress 2018 – ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED Year: 2018 Beta-blockers in pulmonary arterial hypertension: evolving concepts of right heart failure Source: Eur Respir J 2015; 46: 619-621 Year: 2015 ?-blockers in pulmonary arterial hypertension: generation might matter Source: Eur Respir J 2016; 47: 682-684 Year: 2016 Hemodynamic correlates of right ventricular afterload and pulmonary artery pulsatility under treatment with prostacyclin: Retrospective analysis of changes from baseline in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Pulmonary arterial hypertension and CFTR: the paradox of going forward by tacking sideways! Source: Eur Respir J, 58 (5) 2101839; 10.1183/13993003.01839-2021 Year: 2021 Formula for mean pulmonary arterial pressure in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease Year: 2009